Abstract:Background: The World Health Organization (WHO) reported that cardiovascular diseases (CVDs) are the leading cause of death worldwide. CVDs are chronic, with complex progression patterns involving episodes of comorbidities and multimorbidities. When dealing with chronic diseases, physicians often adopt a "watchful waiting" strategy, and actions are postponed until information is available. Population-level transition probabilities and progression patterns can be revealed by applying time-variant stochastic modeling methods to longitudinal patient data from cohort studies. Inputs from CVD practitioners indicate that tools to generate and visualize cohort transition patterns have many impactful clinical applications. The resultant computational model can be embedded in digital decision support tools for clinicians. However, to date, no study has attempted to accomplish this for CVDs. Objective: This study aims to apply advanced stochastic modeling methods to uncover the transition probabilities and progression patterns from longitudinal episodic data of patient cohorts with CVD and thereafter use the computational model to build a digital clinical cohort analytics artifact demonstrating the actionability of such models. Methods: Our data were sourced from 9 epidemiological cohort studies by the National Heart Lung and Blood Institute and comprised chronological records of 1274 patients associated with 4839 CVD episodes across 16 years. We then used the continuous-time Markov chain method to develop our model, which offers a robust approach to time-variant transitions between disease states in chronic diseases. Results: Our study presents time-variant transition probabilities of CVD state changes, revealing patterns of CVD progression against time. We found that the transition from myocardial infarction (MI) to stroke has the fastest transition rate (mean transition time 3, SD 0 days, because only 1 patient had a MI-to-stroke transition in the dataset), and the transition from MI to angina is the slowest (mean transition time 1457, SD 1449 days). Congestive heart failure is the most probable first episode (371/840, 44.2%), followed by stroke (216/840, 25.7%). The resultant artifact is actionable as it can act as an eHealth cohort analytics tool, helping physicians gain insights into treatment and intervention strategies. Through expert panel interviews and surveys, we found 9 application use cases of our model. Conclusions: Past research does not provide actionable cohort-level decision support tools based on a comprehensive, 10-state, continuous-time Markov chain model to unveil complex CVD progression patterns from real-world patient data and support clinical decision-making. This paper aims to address this crucial limitation. Our stochastic model–embedded artifact can help clinicians in efficient disease monitoring and intervention decisions, guided by objective data-driven insights from real patient data. Furthermore, the proposed model can unveil progression patterns of any chronic disease of interest by inputting only 3 data elements: a synthetic patient identifier, episode name, and episode time in days from a baseline date.

Analysis of chronic diseases progression using stochastic modeling

Continuous Time Markov Chains for Analysis of Non-Alcoholic Fatty liver Disease Evolution

Modeling Monotone Nonlinear Disease Progression and Checking the Correctness of the Associated Software

Development of a Cohort Analytics Tool for Monitoring Progression Patterns in Cardiovascular Diseases: Advanced Stochastic Modeling Approach

A Multi-state Non-Markov Framework to Estimate Progression of Chronic Disease

Non-Invasive Diagnosis of Liver Fibrosis in Chronic Hepatitis C using Mathematical Modeling and Simulation

Modeling Chronic Disease Mortality by Methods From Accelerated Life Testing

Nonlinear State Space Modeling and Control of the Impact of Patients' Modifiable Lifestyle Behaviors on the Emergence of Multiple Chronic Conditions

Stochastic model of Alzheimer’s disease progression using two-state Markov chains

A Probabilistic Disease Progression Model for Predicting Future Clinical Outcome

Dynamic Functional Continuous Time Bayesian Networks for Prediction and Monitoring of the Impact of Patients’ Modifiable Lifestyle Behaviors on the Emergence of Multiple Chronic Conditions

Robust parametric modeling of Alzheimer's disease progression

Modeling Disease Progression Trajectories from Longitudinal Observational Data

Joint Dynamic Models and Statistical Inference for Recurrent Competing Risks, Longitudinal Marker, and Health Status

Automated medical diagnosis with fuzzy stochastic models: monitoring chronic diseases

A Medical Decision Making Study based on Markov Chain Model

Modeling disease progression in longitudinal EHR data using continuous-time hidden Markov models

A joint model for multistate disease processes and random informative observation times, with applications to electronic medical records data

Learning transition times in event sequences: the Event-Based Hidden Markov Model of disease progression

Scalable Modeling of Multivariate Longitudinal Data for Prediction of Chronic Kidney Disease Progression

Cost-effectiveness analysis of treatments for chronic disease: using R to incorporate time dependency of treatment response